Cargando…
Acute Valproate-Induced Encephalopathy in Status Epilepticus: A Registry-Based Assessment
BACKGROUND: Valproate-induced encephalopathy (VIE) affects between 0.1% and 2.5% of patients under long-term epilepsy treatment. Its frequency and characteristics in adults with status epilepticus (SE) is, however, unknown. OBJECTIVE: The aim of this study was to characterize the frequency and the c...
Autores principales: | Loser, Valentin, Novy, Jan, Beuchat, Isabelle, Rossetti, Andrea O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439035/ https://www.ncbi.nlm.nih.gov/pubmed/37466895 http://dx.doi.org/10.1007/s40263-023-01024-5 |
Ejemplares similares
-
Clonazepam Loading Dose in Status Epilepticus: Is More Always Better?
por: D’Anto, Jennifer, et al.
Publicado: (2023) -
Valproate in status epilepticus: Correlation between loading dose, serum levels, and clinical response
por: Vijiala, Sergiu, et al.
Publicado: (2022) -
Ketamine in adult super‐refractory status epilepticus: Efficacy analysis on a prospective registry
por: Caranzano, Leonardo, et al.
Publicado: (2022) -
Sodium valproate compared to phenytoin in treatment of status epilepticus
por: Amiri‐Nikpour, Mohammad Reza, et al.
Publicado: (2018) -
Sodium valproate suppresses abnormal neurogenesis induced by convulsive status epilepticus
por: Wu, Peng, et al.
Publicado: (2019)